Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,588 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease.
Hong J, Zhang Y, Lai S, Lv A, Su Q, Dong Y, Zhou Z, Tang W, Zhao J, Cui L, Zou D, Wang D, Li H, Liu C, Wu G, Shen J, Zhu D, Wang W, Shen W, Ning G; SPREAD-DIMCAD Investigators. Hong J, et al. Diabetes Care. 2013 May;36(5):1304-11. doi: 10.2337/dc12-0719. Epub 2012 Dec 10. Diabetes Care. 2013. PMID: 23230096 Free PMC article. Clinical Trial.
Glycemic control rate of T2DM outpatients in China: a multi-center survey.
Chen R, Ji L, Chen L, Chen L, Cai D, Feng B, Kuang H, Li H, Li Y, Liu J, Shan Z, Sun Z, Tian H, Xu Z, Xu Y, Yang Y, Yang L, Yu X, Zhu D, Zou D. Chen R, et al. Among authors: feng b. Med Sci Monit. 2015 May 19;21:1440-6. doi: 10.12659/MSM.892246. Med Sci Monit. 2015. PMID: 25986070 Free PMC article.
Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment-naïve Chinese patients: Analysis of results from the CONSENT trial.
Ji L, Liu J, Yang J, Li Y, Liang L, Zhu D, Li Q, Ma T, Xu H, Yang Y, Zeng J, Feng B, Qu S, Li Y, Ma L, Lin S, Wang J, Li W, Song W, Li X, Luo Y, Xi S, Lin M, Liu Y, Liang Z. Ji L, et al. Among authors: feng b. Diabetes Obes Metab. 2018 Apr;20(4):1006-1013. doi: 10.1111/dom.13190. Epub 2018 Jan 22. Diabetes Obes Metab. 2018. PMID: 29227571 Clinical Trial.
A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral antidiabetic drugs: The merit study.
Guo L, Chen L, Chang B, Yang L, Liu Y, Feng B. Guo L, et al. Among authors: feng b. Diabetes Obes Metab. 2018 Dec;20(12):2740-2747. doi: 10.1111/dom.13454. Epub 2018 Aug 2. Diabetes Obes Metab. 2018. PMID: 29961975 Clinical Trial.
3,588 results